Publicações

Anthracyclines Versus No Anthracyclines in the Neoadjuvant Strategy for Her2+Breast Cancer: Real-World Evidence

AuthID
P-00Y-SXB

Author(s)

de Pinho, IS

Luz, P

Alves, L

Lopes-Bras, R

Patel, V

Esperanca-Martins, M

Goncalves, L

Freitas, R

Simao, D

Galnares, MR

Fernandes, I

Criado, SA

Casado, SG

Canada, JB

Vega, IMS

Costa, JG

Fernandes, AS

de Sousa, RT

Costa, L

Tipo de Documento

Article in Press

Year published

2023

Publicado

in CLINICAL DRUG INVESTIGATION, ISSN: 1173-2563

Indexing

Wos^®

Scopus^®

Pubmed^®

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.1007/s40261-023-01291-6

Pubmed: 37479867

SCOPUS: 2-s2.0-85165269029

Wos: WOS:001034278800001

Source Identifiers

ISSN: 1173-2563

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

Anthracyclines Versus No Anthracyclines in the Neoadjuvant Strategy for Her2+Breast Cancer: Real-World Evidence

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Anthracyclines Versus No Anthracyclines in the Neoadjuvant Strategy for Her2+Breast Cancer: Real-World Evidence

Links Úteis

Ajuda